Further survival analysis of these five genes with Gene Expression Profiling Interactive Analysis (GEPIA) database revealed that high expression of SFRP2 and THBS2 were associated with a poor prognosis in patients with CRC (Figure 4E–I). This evidence concerns the gene SFRP2 and colorectal carcinoma.